Oxcarbazepine-induced thrombocytopenia.
Mahmud
Jamal
J
Dept. of Psychiatry, Drexel Univ. College of Medicine, Philadelphia, PA, USA. jamalmfr@yahoo.com
Mathews
Maju
M
Verma
Sunil
S
Basil
Biju
B
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000068180:Aripiprazole; D001772:Blood Cell Count / Q000379:methods; D002220:Carbamazepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008875:Middle Aged; D000078330:Oxcarbazepine; D010879:Piperazines / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced*; D000069470:Venlafaxine Hydrochloride
D000927:Anticonvulsants; D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003511:Cyclohexanols; D010879:Piperazines; D015363:Quinolones; D002220:Carbamazepine; D000069470:Venlafaxine Hydrochloride; D000068180:Aripiprazole; D000078330:Oxcarbazepine